查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2001098

腎臟和泌尿系統醫療設備市場：2026-2032年全球市場預測（按產品、技術、分銷管道、應用和最終用戶分類）

Nephrology & Urology Devices Market by Product, Technology, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腎臟和泌尿系統醫療設備市場價值將達到 193.6 億美元，到 2026 年將成長至 215.6 億美元，到 2032 年將達到 414.2 億美元，複合年成長率為 11.47%。

主要市場統計數據
基準年 2025 193.6億美元
預計年份：2026年 215.6億美元
預測年份 2032 414.2億美元
複合年成長率 (%) 11.47%

簡要概述人口壓力、臨床需求和技術融合如何重塑腎臟和泌尿系統醫療設備的策略。

受人口結構變化、臨床需求和技術融合的驅動，全球腎臟和泌尿系統醫療設備市場正經歷快速創新和結構性變革。慢性腎臟病的高發生率持續影響透析的需求，而微創泌尿系統手術的進步正在重新定義腎結石、攝護腺疾病和尿失禁的治療標準。同時，醫療服務模式向居家護理、門診手術和數位後續觀察的轉變，迫使製造商和供應商重新思考產品設計、分銷和支援服務。

微創手術、居家照護和數位醫療的融合如何重塑產品設計、照護路徑和商業化模式。

由於技術、臨床和商業性變革的融合，腎臟和泌尿系統醫療設備領域正經歷著一場變革，這些變革正在改變產品的生命週期和治療路徑。微創技術以及雷射和聲學療法的進步提高了手術的精準度並縮短了恢復時間，促使醫院和門診手術中心優先選擇能夠最佳化處理能力和提升患者體驗的醫療設備。同時，居家透析和攜帶式血液透析系統的普及催生了新的照護模式，這些模式優先考慮患者的自主性並減輕醫療機構的負擔，從而影響著醫療設備在安全性、易用性和遠端監測方面的設計。

本研究評估了 2025 年美國關稅趨勢將如何重塑醫療設備各產品類別的採購、製造地和商業談判。

預計美國將在2025年採取關稅措施並調整貿易政策，促使製造商和供應鏈相關人員重新評估籌資策略、生產地點和定價方式。關稅帶來的成本壓力可能會增加進口零件和成品的到貨成本，進而影響與醫院、透析中心和經銷商的採購談判。為此，企業正在探索近岸外包、供應商多元化和加強垂直整合等策略，以保護利潤率並維持穩定的供應鏈。

詳細的細分分析突顯了推動臨床和商業策略的產品、應用、技術、最終用戶和通路趨勢。

細分市場洞察揭示了不同產品、應用、終端用戶、技術和分銷管道之間存在的細微需求差異，這些差異都會影響研發重點和市場進入策略。在產品細分方面，導尿管和輸尿管支架仍然是需求穩定的基本一次性產品，而內視鏡和體外震波碎石設備則在微創治療逐漸成為標準療法的領域被優先考慮。透析設備系列尤其值得關注，它涵蓋了連續性腎臟替代療法 (CRRT) 系統、血液透析過濾器、血液透析系統和腹膜透析系統。在血液透析系統方面，家庭環境和醫療機構環境之間存在顯著差異，這會影響自動化、安全連鎖和遠端監控等設備功能。

美洲、歐洲、中東、非洲和亞太地區在監管、還款和基礎設施方面的區域差異如何決定部署路徑和商業性優先事項。

區域趨勢對三大主要地理叢集（美洲、歐洲、中東和非洲以及亞太地區）的普及曲線、監管力度和商業模式均有顯著影響。在美洲，成熟的醫療基礎設施和不斷擴展的居家照護計畫推動了居家血液透析的普及和數位化設備的部署，而採購則傾向於優先考慮生命週期成本和已證實的臨床療效。在美洲地區內部，不同司法管轄區在報銷模式和醫院採購實踐方面的差異顯而易見，這影響普及的時間和規模。

競爭動態展示了成熟企業、利基創新者和服務主導策略如何塑造產品系列、夥伴關係和市場差異化。

腎臟和泌尿系統醫療設備領域的競爭格局呈現出多元化的態勢，既有成熟的醫療設備醫療設備，也有專注於特定治療方法和數位化改進的新興企業。市場領導利用其規模優勢，投資於整合了資本設備、耗材和遠端監測的整合系統，從而與透析中心和醫院建立牢固的服務關係。同時，一些專業公司則透過針對性的創新，例如一次性內視鏡、先進的體外碎石技術和小型家用透析平台，來應對特定的臨床挑戰和營運限制，從而實現差異化競爭。

為製造商和供應商提供可操作的策略性舉措，以協調創新、供應鏈韌性和服務主導的商業化，從而建立永續的市場優勢。

產業領導企業應優先採取一系列切實可行的措施，以確保在快速變化的環境中，臨床應用和營運能夠保持韌性。首先，透過與臨床醫生合作設計醫療設備，並融入遠端監測功能和使用者友善設計，使研發投資與實際臨床工作流程保持一致，從而減輕培訓負擔。其次，建構靈活的製造和供應商網路，實現跨區域的快速生產分配，以降低關稅和地緣政治風險，同時確保產品品質和合規性。

檢驗我們的發現，該方法結合了臨床醫生的直接見解、全面的二次研究和嚴格的數據三角驗證。

本分析的調查方法結合了定性研究、有針對性的二手研究以及嚴格的三角檢驗，以確保研究結果具有實用性和實證性。一手數據包括對臨床醫生、醫院和透析中心採購經理、技術開發人員以及銷售合作夥伴的結構化訪談，旨在收集關於臨床需求、推廣障礙和服務期望的第一手觀點。除這些訪談外，由執業腎臟科醫生和泌尿系統組成的顧問小組也對研究結果進行了審查，檢驗臨床有效性和治療趨勢。

本報告總結了腎臟和泌尿系統醫療設備市場成功所需的臨床、技術和商業性要求的交集。

總而言之，腎臟和泌尿系統醫療設備市場正處於一個轉折點，人口結構變化、臨床創新和不斷演變的醫療模式相互交織，既帶來了機遇，也帶來了挑戰。居家護理和微創手術的普及推動了以患者為中心設計、具備互聯性和易於維護的醫療設備的需求成長。同時，商業性成功取決於可驗證的療效、供應鏈的靈活性以及能夠將產品經濟效益與更廣泛的醫療保健價值目標相契合的經營模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：腎臟及泌尿系統醫療設備市場：依產品分類

  • 導管
  • 透析設備
    • 連續性腎臟替代療法系統
    • 血液透析過濾器
    • 血液透析系統
    • 腹膜透析系統
  • 內視鏡
  • 破碎設備
  • 輸尿管支架

第9章：腎臟及泌尿系統醫療設備市場：依技術分類

  • 聲波技術
  • 電化學技術
  • 雷射技術
  • 超過濾技術

第10章：腎臟和泌尿系統醫療設備市場：按分銷管道分類

  • 直銷
  • 銷售代理
  • 電子商務

第11章：腎臟和泌尿系統醫療設備市場：按應用領域分類

  • 腎衰竭的治療
    • CrRt
    • 血液透析
    • 腹膜透析
  • 腎結石清除
    • 體外震波碎石術
    • 雷射碎石術
  • 攝護腺疾病
  • 尿失禁的治療

第12章：腎臟與泌尿系統醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 透析中心
  • 居家醫療設施
  • 醫院

第13章：腎臟與泌尿系統醫療設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：腎臟及泌尿系統醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：腎臟與泌尿系統醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國腎臟及泌尿系統醫療設備市場

第17章：中國腎臟與泌尿系統醫療設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • Convatec Group plc
  • Cook Group Incorporated
  • Dornier MedTech
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Medtronic plc
  • Nipro Corporation
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-F927BA462957

The Nephrology & Urology Devices Market was valued at USD 19.36 billion in 2025 and is projected to grow to USD 21.56 billion in 2026, with a CAGR of 11.47%, reaching USD 41.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.36 billion
Estimated Year [2026] USD 21.56 billion
Forecast Year [2032] USD 41.42 billion
CAGR (%) 11.47%

A concise orientation to how demographic pressures, clinical demand, and technological convergence are reshaping nephrology and urology device strategies

The global landscape for nephrology and urology devices is undergoing a period of concentrated innovation and structural change driven by demographic pressures, clinical demand, and technological convergence. Chronic kidney disease prevalence continues to shape demand for dialysis modalities while advances in minimally invasive urologic procedures are redefining standards of care for kidney stones, prostate disorders, and urinary incontinence. Meanwhile, the shifting delivery models in healthcare-toward home-based therapies, ambulatory surgical care, and digitally enabled follow-up-are compelling manufacturers and providers to rethink product design, distribution, and support services.

Investors and clinical leaders must consider not only device performance but also lifecycle economics, interoperability with digital platforms, and regulatory pathways that influence product launch timing. As cost containment and value-based procurement intensify, supplier relationships with hospitals, dialysis centers, and home care providers are increasingly framed around bundled services and outcome-based contracting. Consequently, a clear understanding of clinical workflows, patient preferences, and payer dynamics is essential for stakeholders seeking durable differentiation in this sector.

This introduction frames the report's core focus on how evolving clinical needs and technological trajectories intersect with market access, supply chain resilience, and commercialization strategies. It sets the stage for deeper analyses on segmentation, regional dynamics, and the competitive plays that will drive adoption over the coming years.

How convergence of minimally invasive procedures, home-based therapies, and digital health is rewriting product design, care pathways, and commercialization models

The landscape of nephrology and urology devices is being transformed by an overlapping set of technological, clinical, and commercial shifts that are altering product life cycles and care pathways. Minimally invasive technologies and advances in laser and acoustic modalities are increasing procedural precision while reducing recovery times, prompting hospitals and ambulatory surgical centers to prioritize devices that optimize throughput and patient experience. Concurrently, the expansion of home-based dialysis and portable hemodialysis systems is unlocking new models of care that emphasize patient autonomy and reduced facility burden, which in turn influence device design for safety, ease of use, and remote monitoring.

Data-rich devices that integrate sensors and connectivity are enabling predictive maintenance, therapy personalization, and enhanced clinical oversight. Telehealth integration and remote patient monitoring are no longer auxiliary features but core expectations for many end-users seeking continuity of care. This shift to digitally augmented offerings is also changing commercialization strategies: manufacturers that can demonstrate clinical outcomes through real-world data and that provide comprehensive training and service ecosystems gain competitive advantage.

On the commercial front, distribution channels are evolving as direct sales, specialized distributors, and digital marketplaces each play complementary roles. Health systems and payers are increasingly focused on value per episode, driving demand for devices that lower total cost of care while improving outcomes. The intersection of these trends is forcing legacy manufacturers and new entrants alike to accelerate innovation cycles, form strategic partnerships, and re-evaluate pricing and service models to capture long-term adoption.

Assessing how the 2025 United States tariff trajectory will reshape sourcing, manufacturing footprints, and commercial negotiations across device product families

Anticipated tariff measures and trade policy shifts in the United States expected in 2025 are prompting manufacturers and supply-chain stakeholders to reassess sourcing strategies, production footprints, and pricing approaches. Tariff-driven cost pressures are likely to elevate the landed cost of imported components and finished devices, which will ripple through procurement discussions at hospitals, dialysis centers, and distributors. In response, companies are exploring nearshoring, supplier diversification, and increased vertical integration to protect margins and maintain predictable supply.

The cumulative impact will not be uniform across product families. Devices with complex subassemblies or high value-to-weight ratios will experience different economic effects than consumables or high-volume disposables. Procurement teams will intensify scrutiny of total cost of ownership and explore longer-term contracts or alternative sourcing arrangements to mitigate price volatility. At the same time, regulatory and logistical complexity associated with relocating production or qualifying new suppliers may extend lead times and require additional capital investment.

Strategically, firms with flexible manufacturing capabilities and robust quality systems will be better positioned to absorb or offset tariff-induced cost shifts while preserving market access. Collaboration with payers and health systems to align reimbursement models with altered cost structures can ease adoption friction. Moreover, companies that proactively communicate supply-chain risk mitigation and maintain transparent inventory planning will more effectively retain customer confidence during periods of policy-driven disruption.

Detailed segmentation analysis highlighting product, application, technology, end-user, and channel dynamics that determine clinical and commercial strategies

Segmentation insights reveal nuanced demand drivers that vary by product, application, end user, technology, and distribution channel, each influencing R&D focus and go-to-market strategy. Within product segmentation, Catheters and Ureteral Stents continue to be essential disposables with steady demand, while Endoscopes and Lithotripsy Devices are prioritized where minimally invasive interventions are standard practice. The Dialysis Devices group merits particular attention because it includes Continuous Renal Replacement Therapy systems, Hemodiafilters, Hemodialysis Systems, and Peritoneal Dialysis Systems; within Hemodialysis Systems, an important delineation exists between Home Settings and In-Center Settings, which affects device features such as automation, safety interlocks, and telemonitoring.

Application-driven segmentation underscores the clinical pathways that devices must support. Kidney Failure Management spans CRRT, Hemodialysis, and Peritoneal Dialysis, each with distinct clinical workflows and capital-intensity profiles. Kidney Stone Removal differentiates between Extracorporeal Shock Wave Lithotripsy and Laser Lithotripsy, leading to divergent capital equipment and maintenance considerations. Prostate Disorders and Urinary Incontinence Management demand devices that integrate diagnostic precision with therapeutic efficacy and often require coordinated care across urology and continence services.

End-user segmentation further refines market approach: Ambulatory Surgical Centers, Dialysis Centers, Home Care Settings, and Hospitals each present unique procurement processes, staffing models, and clinical priorities, which dictate training, service, and financing requirements. Technology segmentation highlights where innovation is concentrated, including Acoustic Wave Technologies, Electrochemical Technologies, Laser Technologies, and Ultrafiltration Technologies, and these modalities are unevenly distributed across product and application needs. Finally, distribution channel segmentation-comprising Direct Sales, Distributors, and Ecommerce-shapes buyer experience and post-sale support expectations, with digital channels increasing transparency and enabling faster replenishment for consumables.

How regional regulatory, reimbursement, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific determine adoption pathways and commercial priorities

Regional dynamics shape adoption curves, regulatory rigor, and commercial models in meaningful ways across the three major geographic clusters of the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, mature healthcare infrastructure and expanding home-care initiatives are supporting growth in home hemodialysis adoption and digitally enabled device deployment, while procurement tends to emphasize lifecycle cost and proven clinical outcomes. Moving between jurisdictions within the region reveals differences in reimbursement models and hospital purchasing practices that influence timing and scale of adoption.

The Europe, Middle East & Africa complex presents a heterogeneous regulatory and reimbursement environment, where stringent device approvals and localized health technology assessment pathways can lengthen commercialization timelines but also reward demonstrable clinical and cost benefits. In some markets within this region, constrained public budgets push demand toward devices that offer clear efficiency gains or outpatient migration potential. The regulatory focus on patient safety and environmental stewardship also encourages single-use-to-reusable lifecycle evaluations and circular-economy considerations.

Asia-Pacific is characterized by a mix of rapidly modernizing healthcare systems and large, underserved patient populations. Investment in dialysis infrastructure and urology procedural capacity is expanding, and technology adoption is often accelerated by public-private partnerships and government-led initiatives. Manufacturers targeting this region must balance cost-sensitive procurement with the need for robust service networks and culturally tailored patient engagement strategies. Across all regions, localized clinical education, distribution partnerships, and supply-chain resilience are decisive factors for successful market entry and scaling.

Competitive dynamics showing how incumbents, niche innovators, and service-led strategies are shaping product portfolios, partnerships, and market differentiation

Competitive dynamics in nephrology and urology devices reflect a mix of established medtech incumbents, specialized device innovators, and agile emerging firms focused on niche therapies or digital habilitation. Market leaders are leveraging scale to invest in integrated systems that combine capital equipment, consumables, and remote monitoring, thereby creating sticky service relationships with dialysis centers and hospitals. Simultaneously, specialist companies are differentiating through targeted innovations-such as single-use endoscopes, advanced lithotripsy modalities, and compact home dialysis platforms-that address specific clinical pain points and operational constraints.

Strategic activity is concentrated around several themes: consolidation through strategic acquisitions to fill portfolio gaps; partnerships with software and data analytics providers to turn device-generated data into clinical insights; and investment in manufacturing flexibility to support regional production or rapid ramp-up. Supply-chain partnerships and service excellence are increasingly important competitive levers as customers prioritize uptime and predictable consumable supply. New entrants that can demonstrate clinical validation and regulatory readiness may disrupt traditional procurement cycles, but scaling commercial operations and establishing trust with institutional buyers remain significant execution challenges.

Ultimately, companies that combine differentiated clinical performance with comprehensive lifecycle support-training, maintenance, and outcome measurement-are best positioned to capture long-term customer relationships, while nimble innovators can win pockets of rapid adoption by solving specific clinician or patient pain points.

Actionable strategic initiatives for manufacturers and providers to align innovation, supply-chain resilience, and service-led commercialization for durable market advantage

Industry leaders should prioritize a set of actionable initiatives to secure clinical adoption and operational resilience in a rapidly evolving environment. First, align R&D investments with real-world clinical workflows by co-designing devices with clinicians and incorporating remote monitoring and usability features that reduce training burden. Second, build flexible manufacturing and supplier networks that permit rapid allocation of production across regions to mitigate tariff and geopolitical risk while maintaining quality and regulatory compliance.

Third, expand service-oriented business models that bundle capital equipment with consumables, training, and digital monitoring to create differentiated value propositions and recurring revenue streams. Fourth, invest in robust real-world evidence programs and clinical partnerships to generate outcome data that supports reimbursement discussions and procurement decisions. Fifth, tailor go-to-market approaches by end-user segment; for example, prioritize user-friendly home dialysis systems for home care settings and high-throughput, durable devices for in-center use.

Finally, strengthen commercial agility by developing multi-channel distribution strategies that combine direct sales for complex capital equipment with distributor and e-commerce channels for consumables and smaller devices. Cultivate transparent communications with customers about supply-chain mitigation, and design pricing strategies that reflect total cost of care improvements rather than unit price alone. Together, these actions will enhance market responsiveness, reduce adoption friction, and position organizations for sustainable growth.

A robust evidence-based approach combining primary clinician insights, comprehensive secondary research, and rigorous data triangulation to validate findings

The research methodology underpinning this analysis combines primary qualitative engagement, targeted secondary research, and rigorous triangulation to ensure findings are actionable and evidence-based. Primary inputs include structured interviews with clinicians, procurement leaders at hospitals and dialysis centers, technology developers, and distribution partners to capture firsthand perspectives on clinical needs, adoption barriers, and service expectations. These interviews are supplemented by advisory panel reviews with practicing nephrologists and urologists to validate clinical relevance and procedural trends.

Secondary research encompasses a thorough review of peer-reviewed literature, regulatory agency directives, clinical guidelines, and public-domain white papers to establish clinical and technological context. Market intelligence is then synthesized through cross-validation with supplier disclosures, product registrations, and patent landscapes where appropriate. Quantitative and qualitative inputs are triangulated to reduce bias, and key assumptions are stress-tested through scenario analysis focusing on supply-chain disruptions, policy shifts, and technology adoption rates.

Throughout the process, data quality controls include source verification, consistency checks across datasets, and internal peer reviews. Limitations are acknowledged where data granularity is constrained by proprietary information or rapidly evolving policy environments, and recommendations emphasize areas for periodic updates as new evidence emerges.

Concluding synthesis of the intersecting clinical, technological, and commercial imperatives that define success in nephrology and urology device markets

In summation, the nephrology and urology devices landscape is at an inflection point where demographic pressures, clinical innovation, and shifting care models converge to create both opportunity and complexity. The transition toward home-based therapies and minimally invasive interventions increases demand for devices that prioritize patient-centric design, connectivity, and simplified serviceability. At the same time, commercial success will hinge on demonstrable outcomes, supply-chain agility, and business models that align product economics with broader healthcare value objectives.

Stakeholders who invest in flexible manufacturing, strong clinical partnerships, and comprehensive service ecosystems will be better positioned to navigate regulatory variation and policy-driven cost pressures. Strategic segmentation-by product, application, end user, technology, and distribution channel-enables tailored approaches that address specific adoption drivers. Finally, transparent communication around supply mitigation and real-world performance will remain essential to maintaining trust with institutional buyers and patients as the sector modernizes.

These conclusions underscore the importance of an integrated strategy that balances innovation with operational resilience and commercial adaptability to capture the full potential of nephrology and urology device markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology & Urology Devices Market, by Product

  • 8.1. Catheters
  • 8.2. Dialysis Devices
    • 8.2.1. CrRt Systems
    • 8.2.2. Hemodiafilters
    • 8.2.3. Hemodialysis Systems
    • 8.2.4. Peritoneal Dialysis Systems
  • 8.3. Endoscopes
  • 8.4. Lithotripsy Devices
  • 8.5. Ureteral Stents

9. Nephrology & Urology Devices Market, by Technology

  • 9.1. Acoustic Wave Technologies
  • 9.2. Electrochemical Technologies
  • 9.3. Laser Technologies
  • 9.4. Ultrafiltration Technologies

10. Nephrology & Urology Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors
  • 10.3. Ecommerce

11. Nephrology & Urology Devices Market, by Application

  • 11.1. Kidney Failure Management
    • 11.1.1. CrRt
    • 11.1.2. Hemodialysis
    • 11.1.3. Peritoneal Dialysis
  • 11.2. Kidney Stone Removal
    • 11.2.1. Extracorporeal Shock Wave Lithotripsy
    • 11.2.2. Laser Lithotripsy
  • 11.3. Prostate Disorders
  • 11.4. Urinary Incontinence Management

12. Nephrology & Urology Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Dialysis Centers
  • 12.3. Home Care Settings
  • 12.4. Hospitals

13. Nephrology & Urology Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nephrology & Urology Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nephrology & Urology Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Nephrology & Urology Devices Market

17. China Nephrology & Urology Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Asahi Kasei Corporation
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Becton, Dickinson and Company
  • 18.9. Boston Scientific Corporation
  • 18.10. Coloplast A/S
  • 18.11. Convatec Group plc
  • 18.12. Cook Group Incorporated
  • 18.13. Dornier MedTech
  • 18.14. Fresenius Medical Care AG & Co. KGaA
  • 18.15. Hollister Incorporated
  • 18.16. Medtronic plc
  • 18.17. Nipro Corporation
  • 18.18. Olympus Corporation
  • 18.19. Siemens Healthineers AG
  • 18.20. Stryker Corporation
  • 18.21. Teleflex Incorporated
  • 18.22. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 214. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 215. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)